Studies on the prevalence of oncogenic HPV types among Lithuanian women with cervical pathology

Journal of Medical Virology

Volumn 87, Issue 3, 2015, Pages 461-471

  Simanaviciene, Vaida ^a   Gudleviciene, Zivile ^a   Popendikyte, Violeta ^b   Dekaminaviciute, Dovile ^a   Stumbryte, Ausra ^a   Rubinaite, Vilija ^a   Zvirbliene, Aurelija ^a  

^a VILNIUS UNIVERSITY   (Lithuania)

^b Thermo Fischer Scientific Fermentas   (Lithuania)

Author keywords

Cervical pathology; HPV genotypes; Human papillomavirus

Indexed keywords

VIRUS DNA;

ADULT; AMPLICON; ARTICLE; CANCER GRADING; CARCINOMA IN SITU; CONTROLLED STUDY; CYTODIAGNOSIS; DNA EXTRACTION; FEMALE; GENE AMPLIFICATION; GENE SEQUENCE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 68; HUMAN PAPILLOMAVIRUS TYPE 73; HUMAN PAPILLOMAVIRUS TYPE 82; HUMAN TISSUE; LITHUANIAN (PEOPLE); MAJOR CLINICAL STUDY; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PREVALENCE; SQUAMOUS CELL; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS; ADOLESCENT; AGED; CLASSIFICATION; COMPLICATION; CYTOCHEMISTRY; GENETICS; ISOLATION AND PURIFICATION; LITHUANIA; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PATHOLOGY; UTERINE CERVICAL NEOPLASMS; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENOTYPE; HISTOCYTOCHEMISTRY; HUMANS; LITHUANIA; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84921407378     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24073     Document Type: Article

References (36)

1. Agoff SN, Lin P, Morihara J, Mao C, Kiviat NB, Koutsky LA. 2003. p16(INK4a) expression correlates with degree of cervical neoplasia: a comparison with Ki-67 expression and detection of high-risk HPV types. Mod Pathol 16:665-673.
2. Aleknaviciene B, Smailyte G, Elaawar B, Kurtinaitis J. 2002. Cervical cancer: Recent trends of incidence and mortality in Lithuania. Medicina 38:223-230.
3. Baseman JG, Koutsky LA. 2005. The epidemiology of human papillomavirus infections. J Clin Virol 32:16-24.
4. Bernard HU, Burk RD, Chen Z, van Doorslaer K, Hausen HZ, de Villiers EM. 2010. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virol J 401:70-79.
5. Bosch FX, Burchell AN, Schiffman M, Giuliano AR, Sanjose S, Bruni L, Tortolero-Luna G, Kjaer SK, Muñoz N. 2008. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 26:1-16.
6. Bray F, Sankila R, Ferlay J, Parkin DM. 2002. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer 38:99-166.
7. Bruni L, Diaz M, Castellsague X, Ferrer E, Bosch FX, Sanjose SD. 2010. Cervical human papillomavirus prevalence in 5 continents: Meta-analysis of 1 million women with normal cytological findings. J Infect Dis 202:1789-1799.
8. De Sanjosé S, Diaz M, Castellsagué X, Clifford G, Bruni L, Muñoz N, Bosch FX. 2007. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: A meta-analysis. Lancet Infect Dis 7:453-459.
9. De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S. 2009. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: A meta-analysis. Int J Cancer 124:1626-1636.
10. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. 2010. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893-2917.
11. Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlee F, Hildesheim A, Schiffman MH, Scott DR, Apple RJ. 2000. Improved amplification of genital human papillomaviruses. J Clin Microbiol 38:357-361.
12. Gravitt PE, van Doorn LJ, Quint W, Schiffman M, Hildesheim A, Glass AG, Rush BB, Hellman J, Sherman ME, Burk RD, Wang SS. 2007. Human papillomavirus (HPV) genotyping using paired exfoliated cervicovaginal cells and paraffin-embedded tissues to highlight difficulties in attributing HPV types to specific lesions. J Clin Microbiol 45:3245-3250.
13. Gudleviciene Z, Didziapetriene J, Suziedelis K, Lapkauskaite L. 2005. Investigation of human papillomavirus, its types and variants. Medicina 41:910-915.
14. Gudleviciene Z, Didziapetriene J, Ramael M, Uleckiene S, Valuckas KP. 2006. Human papillomavirus and p53 polymorphism in Lithuanian cervical cancer patients. Gynecol Oncol 102:530-533.
15. Hoory T, Monie A, Gravitt P, Wu TC. 2008. Molecular epidemiology of human papillomavirus. J Formos Med Assoc 107:198-217.
16. Husman R, Walboomers MM, Brule AJC, Chris JL, Meijer M, Snijders JF. 1995. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76:1057-1062.
17. Jarrell MA, Heintz N, Howard P, Collins C, Badger G, Belinson J, Nason F. 1992. Squamous cell carcinoma of the cervix: HPV 16 and DNA ploidy as predictors of survival. Gynecol Oncol 46:361-366.
18. Kovacs K, Varnai AD, Bollmann M, Bankfalvi A, Szendy M, Speich N, Schmitt C, Pajor L, Bollmann R. 2008. Prevalence and genotype distribution of multiple human papillomavirus infection in the uterine cervix: a 7.5-year longitudinal study in a routine cytology-based screening population in West Germany. J Med Virol 80:1814-1823.
19. Li N, Franceschi S, Howell-Jones R, Snijders PJF, Clifford GM. 2011. Human papillomavirus type distribution in 30, 848 invasive cervical cancers worldwide: variation by geographical region, histological type and year of publication. Int J Cancer 128:927-935.
20. Longworth MS, Laimins LA. 2004. Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol Mol Biol Rev 68:362-372.
21. Lu B, Kumar A, Castellsague X, Giuliano AR. 2011. Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: A systematic review & meta-analysis. BMC Infect Dis 11:13.
22. Maver PJ, Seme K, Korac T, Dimitrov G, Dobrossy L, Engele L, Iljazovic E, Kesic V, Kostova P, Lausevic D, Maurina A, Nicula FA, Panayotova Y, Primic Zakelj, Repse M, Fokter A, Romejko-Wolniewicz E, Smailyte G, Şuteu O, Swiderska-Kiec J, Tachezy R, Valerianova Z, Veerus P, Viberga I, Znaor A, Zubor P, Poljak M. 2013. Cervical cancer screening practices in Central and Eastern Europe in 2012. Acta Dermatovenerol Alp Pannonica Adriat 22:7-19.
23. Medeiros LR, Hilgert JB, Zanini RR, Berwanger O, Bozzetti MC, Mylius LC. 2005. Vertical transmission of human papillomavirus: A systematic quantitive review. Cad Saude Publica 21:1006-1015.
24. Merck Sharp & Dohme Corp. Broad spectrum HPV (Human Papillomavirus) vaccine study in 16 to 26 year-old women (V503-001). In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 [cited 2007 Oct 12]. Available from: http://clinicaltrials.gov/show/NCT00543543 NLM identifier: NC T00543543
25. Pagliusi SR, Aguado MT. 2004. Efficacy and other milestones for human papillomavirus vaccine introduction. Vaccine 23:569-578.
26. Popendikyte V, Gulbinovic I, Paulauskiene V, Paulauskas D. 2008. High risk human papilloma virus detection and genotyping by multiplex PCR. Lietuvos Akuserija ir Ginekologija (Lithuanian Obstet Gynecol) 11:348-352.
27. Romanowski B. 2011. Long term protection against cervical infection with the human papillomavirus: Review of currently available vaccines. Hum Vaccin 7:161-169.
28. Sandri MT, Riggio D, Salvatici M, Passerini R, Zorzino L, Boveri S, Radice D, Spolti N, Sideri M. 2009. Typing of human papillomavirus in women with cervical lesions: Prevalence and distribution of different genotypes. J Med Virol 81:271-277.
29. Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, Munoz N, Bosch FX. 2007. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: A meta-analysis. Lancet Infect Dis 7:453-459.
30. Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC, Castle PE. 2011. Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst 103:368-383.
31. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Clifford GM. 2007. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update. Int J Cancer 121:621-632.
32. Trottier H, Franco EL. 2006. The epidemiology of genital human papillomavirus infection. Vaccine 30:1-15.
33. Trottier H, Mahmud S, Costa MC, Sobrinho JP, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL, Franco EL. 2006. Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol Biomarkers Prev 15:1274-1280.
34. Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. 2004. Classification of papillomaviruses. Virology 324:17-27.
35. Wentzensen N, Schiffman M, Dunn T, Zuna RE, Gold MA, Allen RA, Zhang R, Sherman ME, Wacholder S, Walker J, Wang SS. 2009. Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants. Int J Cancer 125:2151-2158.
36. Zuna RE, Allen RA, Moore WE, Lu Y, Mattu R, Dunn ST. 2007. Distribution of HPV genotypes in 282 women with cervical lesions: evidence for three categories of intraepithelial lesions based on morphology and HPV type. Mod Pathol 20:167-174.